SIU Academy® - Official eLearning Portal of SIU (Société Internationale d'Urologie)

Influence of the Covid-19 Pandemic on Accessibility to Surgical Care Among Bladder Cancer Patients
SIU Academy®. Ng'ang'a Kimani E. 11/12/21; 342634; MP-01.07 Topic: Health Economics
Ernest Ng'ang'a Kimani
Ernest Ng'ang'a Kimani
Contributions
Abstract
Influence of the Covid-19 Pandemic on Accessibility to Surgical Care Among Bladder Cancer Patients

Topic: Bladder Cancer

Applicant 1: Ernest Ng\'ang\'a, Applicant 2: Peter, Applicant 3: Francis

Applicant 1: Kimani, Applicant 2: Ndaguatha, Applicant 3: Owilla

Applicant 1: University of Nairobi, Applicant 2: University of Nairobi, Applicant 3: University of Nairobi

Applicant 1: Kenya, Applicant 2: Kenya, Applicant 3: Kenya

Applicant 1: Presenting Author, Applicant 2: Author/Co-Author, Applicant 3: Author/Co-Author

Introduction and Objectives:

With the emergence of the Covid-19 pandemic, access to surgical services in many hospitals has been greatly affected resulting in cancellations of elective theatre services and possible escalation in costs and delay to accessing treatment. This study sought to investigate the influence of the Covid-19 pandemic on healthcare costs and timely accessibility to surgical services among bladder cancer patients undergoing Cystoscopy/TURBT at a hospital in Nairobi, Kenya. 

Materials and Methods:

Thirty-eight patients on follow-up for bladder cancer since August 2019 to December 2020 were randomly sampled. From their past medical records, data was collected on clinical characteristics, total healthcare costs incurred during an inpatient admission as well as duration of delay to accessing surgical services. The independent t-test and Chi-square test were used to assess associations relative to the emergence of the Covid-19 pandemic in March 2020.

Results:

The mean age was 53.3 years (SD 14.75, range 25 to 84). The cohort was 89.7% male and 10.3% female. Ta lesions were 20.7%, pT1 41.4%, T2 24.1%, T3 10.3%, and T4 3.5%. The mean duration to presentation after the onset of hematuria was 7.9 months (range 1 to 48) with older people more likely to present late than younger people (p= .001). The cost of surgical services increased significantly (p= .002) after the onset of the Covid-19 pandemic. There was no significant change in duration to accessing the initial cystoscopy/TURBT. However, accessing subsequent cystoscopy sessions was severely affected in the overall group with over 50% of patients accessing a second session 12 months after the initial. Significantly fewer patients (<.001) were able to access post-surgical intra-vesical chemotherapy after the onset of the Covid-19 pandemic.

Conclusion:

This study enlightens on the need to mitigate costs and duration of accessing cystoscopy/TURBT procedure and chemotherapy among bladder cancer patients with the onset of the Covid-19 pandemic. This would help ensure that surgical care, among other specialized services, is timely and affordable thus reducing tumour recurrence and progression rates.

Influence of the Covid-19 Pandemic on Accessibility to Surgical Care Among Bladder Cancer Patients

Topic: Bladder Cancer

Applicant 1: Ernest Ng\'ang\'a, Applicant 2: Peter, Applicant 3: Francis

Applicant 1: Kimani, Applicant 2: Ndaguatha, Applicant 3: Owilla

Applicant 1: University of Nairobi, Applicant 2: University of Nairobi, Applicant 3: University of Nairobi

Applicant 1: Kenya, Applicant 2: Kenya, Applicant 3: Kenya

Applicant 1: Presenting Author, Applicant 2: Author/Co-Author, Applicant 3: Author/Co-Author

Introduction and Objectives:

With the emergence of the Covid-19 pandemic, access to surgical services in many hospitals has been greatly affected resulting in cancellations of elective theatre services and possible escalation in costs and delay to accessing treatment. This study sought to investigate the influence of the Covid-19 pandemic on healthcare costs and timely accessibility to surgical services among bladder cancer patients undergoing Cystoscopy/TURBT at a hospital in Nairobi, Kenya. 

Materials and Methods:

Thirty-eight patients on follow-up for bladder cancer since August 2019 to December 2020 were randomly sampled. From their past medical records, data was collected on clinical characteristics, total healthcare costs incurred during an inpatient admission as well as duration of delay to accessing surgical services. The independent t-test and Chi-square test were used to assess associations relative to the emergence of the Covid-19 pandemic in March 2020.

Results:

The mean age was 53.3 years (SD 14.75, range 25 to 84). The cohort was 89.7% male and 10.3% female. Ta lesions were 20.7%, pT1 41.4%, T2 24.1%, T3 10.3%, and T4 3.5%. The mean duration to presentation after the onset of hematuria was 7.9 months (range 1 to 48) with older people more likely to present late than younger people (p= .001). The cost of surgical services increased significantly (p= .002) after the onset of the Covid-19 pandemic. There was no significant change in duration to accessing the initial cystoscopy/TURBT. However, accessing subsequent cystoscopy sessions was severely affected in the overall group with over 50% of patients accessing a second session 12 months after the initial. Significantly fewer patients (<.001) were able to access post-surgical intra-vesical chemotherapy after the onset of the Covid-19 pandemic.

Conclusion:

This study enlightens on the need to mitigate costs and duration of accessing cystoscopy/TURBT procedure and chemotherapy among bladder cancer patients with the onset of the Covid-19 pandemic. This would help ensure that surgical care, among other specialized services, is timely and affordable thus reducing tumour recurrence and progression rates.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies